Vaccination News
Breaking News Archives - each day's breaking news from December 1, 2003 (check here for breaking news you might have missed and breaking news that didn't ever hit the "front page")
More News - all the news most recently posted on this website
All the News - a running tab of everything posted on this website since October 29, 2003
Top Stories Archives - daily breaking and other important news stories
Daily News Archives - all the news posted on this website each day (from April 2001)
Hot Topics - selected stories, by category
Return to Vaccination News Home Page (for best results, right click to "open in new window")
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
click here to download Adobe Reader click here for Picks of the Week click here for the old "Recommended List"
Subject: Six-In-One Vaccine Safe And Effective
Safe and effective? 2 died of "SIDS" in the study out of 423 total
(1/2%). That's way out of line with "SIDS" frequency in the
population. Junk statistics again, vaccine manufacturer gets away with murder.
MB
+++++++++++++++++++++++++
"Two children in the Hexavac group died of sudden infant death syndrome
(SIDS) during the study, but an outside review concluded that the deaths were
not related to the vaccine. Both children had been placed down to sleep on
their stomachs, a practice that increases the risk of SIDS." I CAN'T believe this statement - it is
always everything but a vaccine!
Sheri
http://dailynews.yahoo.com/h/nm/20010126/hl/vaccine_1.html
Friday January 26 10:21 AM ET
Six-In-One Vaccine Safe And Effective
By Merritt McKinney
NEW YORK (Reuters Health) - A new vaccine designed to protect children against
six different illnesses appears to provide similar immunity as a combination of
two separate vaccines, according to results of a trial that compared the two
regimens.
The new vaccine did cause a few more mild side effects after the first dose,
but the benefits of the vaccine heavily outweigh its drawbacks, one of the
study's authors told Reuters Health.
``Reducing the number of injections will...be much welcomed by infants and
parents,'' according to Dr. Luc Hessel, the executive director of the medical
department of Aventis Pasteur MSD, the manufacturer of the new vaccine,
Hexavac.
Hexavac, which is approved for use in the European Union (news - web sites) but
not in the US, provides immunity against diphtheria, tetanus, pertussis
(whooping cough), polio, hepatitis B and Haemophilus influenzae B (Hib).
In a study funded by Aventis Pasteur MSD, Hessel and his colleagues compared
Hexavac to two of the company's other vaccines, a hepatitis B vaccine and
Pentavac, which is designed to prevent the other five illnesses. At 2, 4 and 6
months of age, 423 children were immunized with Hexavac while 425 received the
two other vaccines.
Based on 667 infants whose blood samples were available for analysis, the
single vaccine induced similar immune reactions as the two vaccines, suggesting
that it provided children with comparable protection against illness, the
authors report in the December issue of the Pediatric Infectious Disease Journal.
The effects of the vaccines were not identical, however. Hessel's team observed
that antibodies that protect against hepatitis B and Hib disease rose more
slowly in the children immunized with Hexavac. But, according to the
researchers, the differences should not have an effect on a child's immunity
against the illnesses.
``The unique advantage of Hexavac is that it can protect against six
diseases...with a single ready-to-use injection,'' Hessel said. What may take
up to 12 injections if vaccines are given separately, can now be accomplished
with just three to four injections, he explained.
The vaccine ``will also make it easier for countries that have not yet
incorporated all these (vaccines) into their national immunization programs to
adopt these vaccine recommendations more widely,'' Hessel said.
Despite the convenience of the single-dose vaccine, the researchers found that
mild side effects and reactions at the site of the injection were more common
in children who received Hexavac, but, overall, the differences were not
statistically significant. Irritation at the injection site and mild side
effects including irritability or unusual crying were significantly more common
in the Hexavac group after the first dose, but not after the
second and third doses.
Two children in the Hexavac group died of sudden infant death syndrome (SIDS)
during the study, but an outside review concluded that the deaths were not
related to the vaccine. Both children had been placed down to sleep on their
stomachs, a practice that increases the risk of SIDS.
SOURCE: Pediatric Infectious Disease Journal 2000;19:1119-1127.
--------------------------------------------------------
Breaking News Archives - each day's breaking news from December 1, 2003 (check here for breaking news you might have missed and breaking news that didn't ever hit the "front page")
More News - all the news most recently posted on this website
All the News - a running tab of everything posted on this website since October 29, 2003
Top Stories Archives - daily breaking and other important news stories
Daily News Archives - all the news posted on this website each day (from April 2001)
Hot Topics - selected stories, by category
Return to Vaccination News Home Page (for best results, right click to "open in new window")
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.